We’re excited to announce the launch of #VenaCore, the first mechanical #thrombectomy device designed to address the most challenging venous occlusions related to the long-term complications of #DVT. Featuring a laser-cut element with notched leading edges for the in-line treatment of venous occlusions, VenaCore is designed to engage, separate, and remove occlusions. Learn more by registering for our upcoming #ClotWarriorAcademy: https://bit.ly/4bFG12l
Inari Medical
Medical Equipment Manufacturing
Irvine, California 40,355 followers
Extracting Large Clot from Large Vessels
About us
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
- Website
-
http://inarimedical.com/
External link for Inari Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Irvine, California
- Type
- Public Company
Locations
-
Primary
6001 Oak Canyon
Suite 100
Irvine, California 92618, US
Employees at Inari Medical
Updates
-
MD Interventional Radiologist, Director de unidades de Radiologia Intervencionista en Chile, difusión y desarrollo.
El 30 de agosto realizamos en Clínica Alemana de Temuco una Jornada de simulación dirigida a otros colegas de Chile, para tratar trombos venosos #TVP y de arterias pulmonares #TEP #PE #IR La experiencia del equipo de Radiología Intervencionista y el apoyo de Inari Medical nos permitió un trabajo de gran nivel, simuladores avanzados Mentice, modelos de flujo, ecografía intra cardíaca, dispositivos médicos de última generación y la experiencia compartida de forma generosa para ser mejores con nuestros pacientes. 🇨🇱 Sociedad Chilena de Radiología
-
-
-
-
-
+7
-
-
Happy Labor Day! Thank you to the dedicated #PurpleWave team who change lives every day. Today, we're honoring you and the endless contributions you continue to make across our organization. #LaborDay #InariMedical
-
-
nicolas meneveau announces the global #PERSEVERE RCT for acute high-risk PE in a full room at #ESCCongress! "PERSEVERE is the first RCT in high-risk PE in 40 years." #FlowTriever #PulmonaryEmbolism #RandomizedTrial #DataMatters #GoldenAge nicolas meneveau Prof.Dr.Stavros Konstantinides Jay Giri John Moriarty European Society of Cardiology
-
-
#ICYMI: Interim 2-year #CLOUT outcomes show patients treated with #ClotTriever saw significant improvement in #PTS symptoms. CLOUT is the longest patient follow-up after treatment of #DVT with mechanical #thrombectomy. #safety #effectiveness #evidence #VENOUS2024
-
-
The all-new #VenaCore thrombectomy catheter is the only mechanical thrombectomy device specifically designed to address challenging venous occlusions associated with residual venous thrombosis (RVO), a common complication of #DVT. Dr. Ducoffe's case highlights VenaCore's effectiveness in clearing underlying residual venous obstructions, often seen in acute DVT patients, as well as the improved procedure efficiency when targeting focal segments in #ClotTriever BOLD cases. #MedicalInnovation #InariMedical
-
12 days until our next #ClotWarriorAcademy webinar! Designed specifically for #VTE Procedural Techs, this webinar will focus on collaborative strategies and best practices for physicians and techs. Register here: https://bit.ly/4e2NKYP
-
-
Join us at #TCT2024 for the late-breaking #PEERLESS RCT data release! PEERLESS is a randomized trial comparing the #FlowTriever System vs catheter-directed thrombolysis (CDT) for the treatment of intermediate-high risk #PE. #PulmonaryEmbolism #RandomizedTrial #LateBreakers #DataMatters Wissam A Jaber
#TCT2024 Late-Breaking Research Announced! 🚨 🌟 The moment you’ve been waiting for is here! Discover game-changing research that will revolutionize cardiovascular care. Get ready to witness the breakthroughs that will transform your practice and redefine patient outcomes. 🚀 https://ow.ly/rzqS50T80Zt Secure your spot now! 👉 https://ow.ly/L2L150T80Zn #interventionalcardiology Daniel Burkhoff David Cohen George Dangas, MD, MACC, MSCAI Juan Granada Akiko Maehara Roxana Mehran Gary Mintz Sahil Parikh Tricia Rawh
-
Key predictors in #PE management: Ensuring the best decisions What are the key factors in selecting the optimal treatment for #PE? How can we guarantee that each eligible patient gets the appropriate care? Watch this short video as Dr Pablo Salinas and Dr Ana Viana Tejedor share their insights and experiences from Clinico San Carlos in Madrid, Spain. For a deeper dive, join our expert speakers for a practical discussion on new strategies for risk stratification, patient selection, and the latest scientific evidence in #PE management during #ESCCongress. 📅 When: 31 August at 15:15 📍 Where: Valletta Room or Channel 7 (online) Don't miss the #Inari Symposium - be part of the conversation shaping the future of PE management! #InterventionalCardiology #Cardiology #FlowTriever